Cargando…

Effectiveness of azithromycin mass drug administration on trachoma: a systematic review

BACKGROUNDS: Azithromycin mass drug administration (MDA) is a key part of the strategy for controlling trachoma. This systematic review aimed to comprehensively summarize the present studies of azithromycin MDA on trachoma; provide an overview of the impact of azithromycin MDA on trachoma in differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Tao, Yue, Yan, Li, Wen-Xing, Choonara, Imti, Qazi, Shamim, Chen, Hong-Ju, Tang, Jun, Shi, Jing, Wang, Hua, Zeng, Li-Nan, Xia, Bin, Qiao, Li-Na, Qu, Yi, Mu, De-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710348/ https://www.ncbi.nlm.nih.gov/pubmed/34665571 http://dx.doi.org/10.1097/CM9.0000000000001717

Ejemplares similares

Dose and formulation of azithromycin in mass drug administration studies: a systematic review protocol
por: Yue, Yan, et al.
Publicado: (2019)

Safety of azithromycin in paediatrics: a systematic review protocol
por: Xu, Peipei, et al.
Publicado: (2019)

Safety of azithromycin in pediatrics: a systematic review and meta-analysis
por: Zeng, Linan, et al.
Publicado: (2020)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
por: Schachterle, Stephen E., et al.
Publicado: (2014)

Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settings
por: Kigen, Gabriel, et al.
Publicado: (2014)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin
por: Malhotra, Sumit, et al.
Publicado: (2016)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
por: Marks, Michael, et al.
Publicado: (2016)

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
por: Astale, Tigist, et al.
Publicado: (2018)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Correction: Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
Publicado: (2018)

Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia
por: Ebert, Caleb D., et al.
Publicado: (2019)

To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia
por: Feyisa, Tadele, et al.
Publicado: (2022)

Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys
por: Goodhew, E. Brook, et al.
Publicado: (2023)

Use and safety of azithromycin in neonates: a systematic review
por: Smith, Coral, et al.
Publicado: (2015)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Safe mass drug administration and trachoma elimination
por: Addiss, David, et al.
Publicado: (2019)

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control
por: Ghinai, Rosanna, et al.
Publicado: (2015)

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
por: Bojang, Ebrima, et al.
Publicado: (2017)

Prevalence of Trachoma at Sub-District Level in Ethiopia: Determining When to Stop Mass Azithromycin Distribution
por: King, Jonathan D., et al.
Publicado: (2014)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
por: Ho, Derek K-H., et al.
Publicado: (2015)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Epidemiology and control of trachoma: systematic review
por: Hu, Victor H, et al.
Publicado: (2010)

Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness
por: Huguet, P, et al.
Publicado: (2009)

Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
por: West, Sheila K., et al.
Publicado: (2011)

Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds
por: Ssemanda, Elizabeth N., et al.
Publicado: (2012)

Elimination of Active Trachoma after Two Topical Mass Treatments with Azithromycin 1.5% Eye Drops
por: Amza, Abdou, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5pugnnbor335ooht22gm6j30rh